Home » Topics » Regulatory

Regulatory
RSS

MediGene extends clinical development of Polyphenon E to actinic keratosis

April 13, 2004

Primovist receives approval in Sweden

April 7, 2004

Vioxx approved for acute treatment of migraine

April 6, 2004

Use of reboxetine for hot flashes claimed by patent

March 31, 2004

Medac patent claims new use of treosulfan for MS

March 30, 2004

Fosrenol receives approval in Sweden

March 26, 2004

European Commission approves extended labeling for Xenical

March 26, 2004

Ezetimibe/simvastatin tablets approved in Mexico

March 23, 2004

FDA approval for Sensipar

March 11, 2004

Aldara approved for actinic keratoses

March 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...